Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)
China flag China · Delayed Price · Currency is CNY
24.60
+0.45 (1.86%)
Mar 10, 2026, 12:35 PM CST

SHE:300357 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20 2019 - 2015
Cash & Equivalents
1,0551,1191,171840.69649.99583.68
Upgrade
Trading Asset Securities
286.82196.09117.39295.05370.93307.03
Upgrade
Cash & Short-Term Investments
1,3421,3151,2891,1361,021890.71
Upgrade
Cash Growth
7.22%2.03%13.47%11.25%14.62%12.44%
Upgrade
Accounts Receivable
346.17251.04202.92254.31238.12206.77
Upgrade
Other Receivables
6.2--19.8111.138.57
Upgrade
Receivables
352.38251.04202.92274.12249.26215.35
Upgrade
Inventory
53.757.7359.0448.4153.7548.33
Upgrade
Other Current Assets
24.327.7819.1718.8617.5816.55
Upgrade
Total Current Assets
1,7721,6511,5701,4771,3421,171
Upgrade
Property, Plant & Equipment
852.98780.09704.84444.61301.62240.16
Upgrade
Long-Term Investments
77.2677.9474.2178.483.3513.86
Upgrade
Other Intangible Assets
151.86162.79161.38139.679461.01
Upgrade
Long-Term Deferred Tax Assets
6.785.65.034.875.814.9
Upgrade
Long-Term Deferred Charges
28.4225.2734.3853.286.05113.89
Upgrade
Other Long-Term Assets
3.65.9412.42-19.63-
Upgrade
Total Assets
2,8932,7092,5622,1981,9321,605
Upgrade
Accounts Payable
36.0347.777.997.685.085.66
Upgrade
Accrued Expenses
26.9935.1333.5729.8935.5423.15
Upgrade
Short-Term Debt
512.6334.39---
Upgrade
Current Portion of Leases
4.685.036.83.985.86-
Upgrade
Current Income Taxes Payable
33.5110.569.2626.0850.329.59
Upgrade
Current Unearned Revenue
0.630.510.380.420.420.44
Upgrade
Other Current Liabilities
13.170.9584.6434.7110.7816.57
Upgrade
Total Current Liabilities
119.95182.58177.04102.7510855.42
Upgrade
Long-Term Leases
9.727.9321.2612.281.95-
Upgrade
Long-Term Unearned Revenue
32.2233.5330.9327.4324.9120.63
Upgrade
Long-Term Deferred Tax Liabilities
0.090.170.20.080.50.56
Upgrade
Other Long-Term Liabilities
-26.0829.0328.22--
Upgrade
Total Liabilities
161.98250.3258.46170.76135.3676.61
Upgrade
Common Stock
523.58523.58523.58523.58523.58523.58
Upgrade
Additional Paid-In Capital
128.19128.19128.19128.19128.19128.19
Upgrade
Retained Earnings
1,9841,7021,5331,3281,084803.26
Upgrade
Comprehensive Income & Other
0.030.040.030.0300.87
Upgrade
Total Common Equity
2,6362,3542,1851,9801,7361,456
Upgrade
Minority Interest
95.49105.12118.6147.4960.5472.24
Upgrade
Shareholders' Equity
2,7312,4592,3042,0271,7971,528
Upgrade
Total Liabilities & Equity
2,8932,7092,5622,1981,9321,605
Upgrade
Total Debt
19.3925.5962.4416.267.81-
Upgrade
Net Cash (Debt)
1,3231,2891,2261,1191,013890.71
Upgrade
Net Cash Growth
10.13%5.14%9.54%10.50%13.74%12.44%
Upgrade
Net Cash Per Share
2.532.462.342.141.931.70
Upgrade
Filing Date Shares Outstanding
523.58523.58523.58523.58523.58523.58
Upgrade
Total Common Shares Outstanding
523.58523.58523.58523.58523.58523.58
Upgrade
Working Capital
1,6521,4691,3931,3741,2341,116
Upgrade
Book Value Per Share
5.034.504.173.783.322.78
Upgrade
Tangible Book Value
2,4842,1912,0241,8401,6421,395
Upgrade
Tangible Book Value Per Share
4.744.183.873.513.142.66
Upgrade
Buildings
-428.52423.31175.67137.89137.89
Upgrade
Machinery
-135.42115.9995.5177.1171.89
Upgrade
Construction In Progress
-323.16227.86226.24140.3380.46
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.